12:00 AM
 | 
Dec 08, 2008
 |  BioCentury  |  Regulation

Tropical diseases pipeline

Tropical diseases pipeline

Company Product Indication Status
Novartis (NYSE:NVS; SWX:NOVN) Coartem artemether (A)/lumefantrine Malaria Approved ex-U.S.; under review in U.S.
Crucell (Euronext:CRXL; NASDAQ:CRXL) Dukoral vaccine Prevent cholera Approved ex-U.S.
Paladin Labs (TSX:PLB)...

Read the full 279 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >